HealthLight Introduces New Infrared Phototherapy System And $1,000 Cross Grade Allowance For Anodyne Therapy Legacy Equipment
HealthLight's Mini-Pro system combines new features, functionality and practicality into a single backward compatible unit and a $1,000 cross grade allowance for Anodyne Therapy legacy equipment.
Copake, NY (PRWEB) May 5, 2009
Bioremedi Therapeutic Systems Inc introduces the new HealthLight clinical system upgrade along with a $1000 cross grade allowance for users of the Anodyne Pro 8 pad units.
The new HealthLight device combines the features of the professional clinical model with the simplicity of the portable model into a single controller that is backward compatible with all existing HealthLight pad accessories.
One new feature is the infrared detector. Users are easily able to determine if the infrared diodes are working properly. "Infrared light is invisible to the human eye. This challenge was posed repeatedly over the years, so we incorporated this feature in the new design", says Patrick Doyle, president of Bioremedi Therapeutic Systems Inc.
The Mini-Pro is a completly new design. The importance of interoperability with legacy equipment was paramount and compatibility with all existing pad accessories was mandatory. The Mini-Pro controller blends the simplicity of the portable model with the functionality of the clinical model. Two additional automatic programs give practitioners more time saving options than with prior models.
"We also realize that many clinics have non-working or outdated Anodyne Therapy legacy equipment so we decided to offer a $1000 cross grade trade-in allowance to clinics considering upgrading to the HealthLight System" says Patrick Doyle. "In the first week of the launch several clinics have already taken advantage of the offer". The allowance program is designed to run through Dec 31, 2009.
Bioremedi Therapeutic Systems Inc is the manufacturer of HealthLight pulsed infrared devices used primarily for reducing the pain and inflammation often associated with diabetic related peripheral neuropathy.
###
